Zinc levels in Beta-Thalassemia Major: A Review of the Literature
Article Sidebar
Main Article Content
Abstract
Objective: Zinc is an essential trace element for the body that is involved in various significant body functions such as protein synthesis, DNA synthesis, and cellular growth. It is found in almost every cell and plays an important role in the immune system, affecting both innate and acquired immunity. Patients with beta-thalassemia major are at risk of zinc deficiency. Beta-thalassemia major is an inherited disease caused by a reduction or complete absence of beta-globin chains and the affected patients need repeated blood transfusions to survive. Accordingly, it causes oxidative stress and tissue damage, alteration of antioxidant enzymes, and changes in other essential trace element levels due to iron overload. Zinc levels in beta-thalassemia major patients were reported to be significantly reduced in most of the studies. Serum zinc levels of the patients with beta-thalassemia major should be monitored regularly and zinc supplementation should be provided to these patients.
Downloads
Article Details
Accepted 2021-06-11
Published 2021-06-19
References
Ackland ML, Michalczyk A. Zinc deficiency and its inherited disorders -a review. Genes Nutr. 2006;1(1):41-9.
Hemmens B, Goessler W, Schmidt K, Mayer B. Role of bound zinc in dimer stabilization but not enzyme activity of neuronal nitric-oxide synthase. J Biol Chem. 2000;275:35786–91.
Gammoh NZ, Rink L. Zinc in Infection and Inflammation. Nutrients. 2017;9(6):624.
Lu J, Stewart AJ, Sadler PJ, Pinheiro TJT, Blindauer CA. Albumin as a zinc carrier: Properties of its high affinity zinc-binding site. Biochem Soc Trans. 2008;36:1317–21.
Mocchegiani E, Costarelli L, Giacconi R, Cipriano C, Muti E, Malavolta M. Zinc-binding proteins and immunosenescence. Exp Gerontol. 2006;41:1094–107.
Cunningham M. The thalassemias. In: Orkin SH, Nathan DG, Ginsburg D, Look AT, Fisher DE, Lux SE, editors. Nathan and Oski's Hematology of Infancy and Childhood, 7th edition. Philadephia: Saunders Elsevier; 2009. p.1015-106.
Dehshal MH, Hooghooghi AH, Kebryaeezadeh A, Kheirabadi M, Kazemi S, Nasseh A, et al. Zinc deficiency aggravates abnormal glucose metabolism in thalassemia major patients. Med Sci Monit. 2007;13(5):235-9.
Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5:11.
Cunningham MJ, Macklin E, Neufeld EJ, Cohen AR. Complications of B-thalassemia major in North America. Blood. 2004;104:34–9.
Weatherall DJ, Clegg JB. Management and prognosis in the thalassemia syn- dromes. 4th ed. Oxford, UK: Blackwell Scientific; 2001. p:630–85.
Ceci A, Mangiarini L, Felisi M, Bartoloni F, Ciancio A, Capra M, et al. The man- agement of iron chelation therapy: preliminary data from a national registry of thalassaemic patients. Anemia. 2011;2011:435683.
Mehdizadeh M, Zamani G, Tabatabaee S. Zinc status in patients with major
Yakoob MY, Theodoratou E, Jabeen A, Imdad A, Eisele TP, Ferguson J, et al. Preventive zinc supplementation in developing countries: impact on mortality and morbidity due to diarrhea, pneumonia and malaria. BMC Public Health. 2011;11(3):23.
Gibson RS, Ferguson EL. Nutrition intervention strategies to combat zinc deficiency in developing countries. Nutr Res Rev. 1998;11(1):115–31.
Yu M, Lee WW, Tomaretal D. Regulation of T cell receptor signaling by activation-induced zinc influx. J Exp Med. 2011; 208(4):775–85.
Kosarian M, Valaee N, Mahdyyanee A. Do the desferal receiver thalassemic patients have zinc deficiency?. J Mazandaran Univ Med Sci. 2000;26(10):1‐6.
Kwan EY, Lee AC, Li AM, Tam SC, Chan CF, Lau YL, et al. A cross-sectional study of growth, puberty and endocrine function in patients with thalassaemia major in Hong Kong. J Paediatr Child Health. 1995;31(2):83-7.
Moafi A, Mobaraki G, Taheri SS, Heidarzadeh A, Shahabi I, Majidi F. Zinc in thalassemic patients and its relation with depression. Biol Trace Elem Res. 2008;123(1-3):8-13.
Sultan S, Irfan SM, Kakar J, Zeeshan R. Effect of iron chelator desferrioxamine on serum zinc levels in patients with beta thalassemia major. Malaysian J Pathol. 2015;37(1):35 –8.
Fung EB, Kwiatkowski JL, Huang JN, Gildengorin G, King JC, Vichinsky EP. Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial1–3. Am J Clin Nutr. 2013;98:960–71.
Ferdaus MZ, Hasan AK, Shekhar HU. Analysis of serum lipid profiles, metal ions and thyroid hormones levels abnormalities in beta-thalassaemic children of Bangladesh. J Pak Med Assoc. 2010;60(5):360-4.
Nidumuru S, Boddula V, Vadakedath S, Kolanu BR, Kandi V. Evaluating the role of zinc in beta thalassemia major: a prospective case-control study from a tertiary care teaching Hospital in India. Cureus. 2017;9(7):e1495.
Mahyar A, Ayazi P, Pahlevan AA, Mojabi H, Sehhat MR, Javadi A. Zinc and copper status in children with beta¬thalassemia major. Iran J Pediatr. 2010;20 (3): 297-302.
Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pourzahedgilani N, Bouzari N, Habibzadeh M, et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord. 2003;3(1):4.
Tabatabei M, Kamkar M, Habibzadeh MR. Metabolic and endocrine complications in beta‐thalassemia major; a multicenter study in Tehran. Boshehr Med J. 2003;5(1):72‐3.
Bekheirnia MR, Shamshirsaz AA, Kamgar M, Bouzari N, Erfanzadeh G, Pourzahedgilani N, et al. Serum zinc and its relation to bone mineral density in beta-thalassemic adolescents. Biol Trace Elem Res. 2004;97(3):215–24.
Arcasoy A, Canatan D, Sinav B, Kutlay L, Oğuz N, Şen M. Serum zinc levels and zinc binding capacity in thalassemia. J Trace Elem Med Biol. 2001;15:85-7 .
Mashhadi MA, Sepehri Z, Heidari Z, Shirzaee E, Kiani Z. The prevalence of zinc deficiency in patients with thalassemia in South East of iran, sistan and baluchistan province. Iran Red Crescent Med J. 2014;16(8):e6243.
Quirolo K, Vichinnky E. Hemoglobin disorders. In: Behraman RE, editor. Nelson Textbook of Pediatrics. 18th ed. Philadephia: Saunders; 2007. p.2033‐9.
Lukenn JN. The thalassemia and related disorders. In: Richard Lee GR, Foeuster J, Lukens J, Parakeras F, Green J, Rodgers GM, editors. Wintrobes clinical hematology. 18th ed. Philadelphia: Lippincott, Williams & Wilkins: 1999. p.1406‐35.
Pavlova LE, Savov VM, Petkov HG, Charova IP. Oxidative stress in patients with beta-thalassemia major. Prilozi. 2007; 28(1):145–54.
Ghone RA, Kumbar KM, Suryakar AN, Katkam RV, Joshi NG. Oxidative stress and disturbance in antioxidant balance in beta thalassemia major. Indian J Clin Biochem. 2008;23(4):337–40.
Claster S, Wood JC, Noetzli L, Carson SM, Hofstra TC, Khanna R, et al. Nutritional deficiencies in iron overloaded patients with hemoglobinopathies. Am J Hematol. 2009;84(6):344–8.
Anastassopoulou J, Anifantakis B, Anifantakis ZA, Dovas A, Theophanides T. The role of free radical reactions with haemoglobin and thalassaemia. J Inorg Biochem. 2000;79( 1–4):327–9.
Powell SR. The antioxidant properties of zinc. J Nut. 2000;130(Supp l):1447-54.
Rostan EF, DeBuys HV, Madey DL, Pinnell SR. Evidence supporting zinc as an important antioxidant for skin. Int J of Dermatol. 2002;4:606-11.